- Home
- STKS vs SLS Comparison
STKS vs SLS Comparison
Compare STKS & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STKS
- SLS
- Stock Information
- Founded
- STKS 2004
- SLS 2012
- Country
- STKS United States
- SLS United States
- Employees
- STKS N/A
- SLS N/A
- Industry
- STKS Restaurants
- SLS Biotechnology: Pharmaceutical Preparations
- Sector
- STKS Consumer Discretionary
- SLS Health Care
- Exchange
- STKS Nasdaq
- SLS Nasdaq
- Market Cap
- STKS 109.7M
- SLS 169.6M
- IPO Year
- STKS N/A
- SLS N/A
- Fundamental
- Price
- STKS $3.33
- SLS $1.80
- Analyst Decision
- STKS Hold
- SLS Strong Buy
- Analyst Count
- STKS 3
- SLS 1
- Target Price
- STKS $4.83
- SLS $7.00
- AVG Volume (30 Days)
- STKS 340.4K
- SLS 3.7M
- Earning Date
- STKS 08-05-2025
- SLS 08-12-2025
- Dividend Yield
- STKS N/A
- SLS N/A
- EPS Growth
- STKS N/A
- SLS N/A
- EPS
- STKS N/A
- SLS N/A
- Revenue
- STKS $799,478,000.00
- SLS N/A
- Revenue This Year
- STKS $26.92
- SLS N/A
- Revenue Next Year
- STKS $5.39
- SLS N/A
- P/E Ratio
- STKS N/A
- SLS N/A
- Revenue Growth
- STKS 138.50
- SLS N/A
- 52 Week Low
- STKS $2.37
- SLS $0.77
- 52 Week High
- STKS $5.42
- SLS $2.27
- Technical
- Relative Strength Index (RSI)
- STKS 37.71
- SLS 46.63
- Support Level
- STKS $3.31
- SLS $1.75
- Resistance Level
- STKS $4.12
- SLS $1.96
- Average True Range (ATR)
- STKS 0.32
- SLS 0.13
- MACD
- STKS -0.14
- SLS -0.03
- Stochastic Oscillator
- STKS 5.52
- SLS 11.90
About STKS The ONE Group Hospitality Inc.
The One Group Hospitality Inc is a restaurant company that develops, owns and operates, manages and licenses upscale and polished casual, high-energy restaurants and lounges and provides turn-key food and beverage (F&B) services for hospitality venues, including hotels, casinos, and other high-end locations internationally. The company operates through four segments: STK, Benihana and Grill Concepts. The company generates the vast majority of its revenue from the domestic market.
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.